175 related articles for article (PubMed ID: 33025481)
1. A multicentre prospective feasibility study of carbon dye tattooing of biopsied axillary node and surgical localisation in breast cancer patients.
Goyal A; Puri S; Marshall A; Valassiadou K; Hoosein MM; Carmichael AR; Erdelyi G; Sharma N; Dunn J; York J
Breast Cancer Res Treat; 2021 Jan; 185(2):433-440. PubMed ID: 33025481
[TBL] [Abstract][Full Text] [Related]
2. Targeted axillary dissection with preoperative tattooing of biopsied positive axillary lymph nodes in breast cancer.
Gatek J; Petru V; Kosac P; Ratajsky M; Duben J; Dudesek B; Jancik P; Zabojnikova M; Katrusak J; Opelova P; Podrazska L; Vazan P; Kudlova P; Holik P; Melichar B; Vrana D
Neoplasma; 2020 Nov; 67(6):1329-1334. PubMed ID: 32749847
[TBL] [Abstract][Full Text] [Related]
3. Carbon tattooing of axillary lymph nodes in breast cancer patients before neoadjuvant chemotherapy: A retrospective analysis.
Porpiglia M; Borella F; Chieppa P; Brino C; Ala A; Marra V; Castellano I; Benedetto C
Tumori; 2023 Jun; 109(3):301-306. PubMed ID: 35751383
[TBL] [Abstract][Full Text] [Related]
4. False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy.
de Boniface J; Frisell J; Kühn T; Wiklander-Bråkenhielm I; Dembrower K; Nyman P; Zouzos A; Gerber B; Reimer T; Hartmann S
Breast Cancer Res Treat; 2022 Jun; 193(3):589-595. PubMed ID: 35451733
[TBL] [Abstract][Full Text] [Related]
5. Axillary Lymph Node Tattooing and Targeted Axillary Dissection in Breast Cancer Patients Who Presented as cN+ Before Neoadjuvant Chemotherapy and Became cN0 After Treatment.
Natsiopoulos I; Intzes S; Liappis T; Zarampoukas K; Zarampoukas T; Zacharopoulou V; Papazisis K
Clin Breast Cancer; 2019 Jun; 19(3):208-215. PubMed ID: 30922804
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound guided tattooing of axillary lymph nodes in breast cancer patients prior to neoadjuvant therapy, and identification of tattooed nodes at the time of surgery.
Allweis TM; Menes T; Rotbart N; Rapson Y; Cernik H; Bokov I; Diment J; Magen A; Golan O; Levi-Bendet N; Givon Madhala O; Grubstein A
Eur J Surg Oncol; 2020 Jun; 46(6):1041-1045. PubMed ID: 31801656
[TBL] [Abstract][Full Text] [Related]
7. Initial results with preoperative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast cancer patients.
Choy N; Lipson J; Porter C; Ozawa M; Kieryn A; Pal S; Kao J; Trinh L; Wheeler A; Ikeda D; Jensen K; Allison K; Wapnir I
Ann Surg Oncol; 2015 Feb; 22(2):377-82. PubMed ID: 25164040
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Definitive results.
Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL
Surg Oncol; 2021 Sep; 38():101636. PubMed ID: 34303211
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-Guided Fine-Needle Aspiration of Non-palpable and Suspicious Axillary Lymph Nodes with Subsequent Removal after Tattooing: False-Negative Results and Concordance with Sentinel Lymph Nodes.
Kim WH; Kim HJ; Jung JH; Park HY; Lee J; Kim WW; Park JY; Cheon H; Lee SM; Cho SH; Shin KM; Kim GC
Ultrasound Med Biol; 2017 Nov; 43(11):2576-2581. PubMed ID: 28830644
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment Tattoo Marking of Suspicious Axillary Lymph Nodes: Reliability and Correlation with Sentinel Lymph Node.
Patel R; MacKerricher W; Tsai J; Choy N; Lipson J; Ikeda D; Pal S; De Martini W; Allison KH; Wapnir IL
Ann Surg Oncol; 2019 Aug; 26(8):2452-2458. PubMed ID: 31087176
[TBL] [Abstract][Full Text] [Related]
11. Initial experience with targeted axillary dissection after neoadjuvant therapy in breast cancer patients.
Pinto CS; Peleteiro B; Pinto CA; Osório F; Costa S; Magalhães A; Mora H; Amaral J; Gonçalves D; Fougo JL
Breast Cancer; 2022 Jul; 29(4):709-719. PubMed ID: 35304711
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients.
Park S; Koo JS; Kim GM; Sohn J; Kim SI; Cho YU; Park BW; Park VY; Yoon JH; Moon HJ; Kim MJ; Kim EK
Cancer Res Treat; 2018 Jul; 50(3):801-812. PubMed ID: 28814071
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of preoperative tattooing of percutaneously biopsied axillary lymph node: an experimental pilot study.
Sattar AK; Ali B; Masroor I; Afzal S; Tariq MU; Idrees R; Uzzaman M; Khalid W
Pilot Feasibility Stud; 2020; 6():140. PubMed ID: 32983557
[TBL] [Abstract][Full Text] [Related]
14. Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101).
Weber WP; Matrai Z; Hayoz S; Tausch C; Henke G; Zwahlen DR; Gruber G; Zimmermann F; Seiler S; Maddox C; Ruhstaller T; Muenst S; Ackerknecht M; Kuemmel S; Bjelic-Radisic V; Kurzeder C; Újhelyi M; Vrieling C; Satler R; Meyer I; Becciolini C; Bucher S; Simonson C; Fehr PM; Gabriel N; Maráz R; Sarlos D; Dedes KJ; Leo C; Berclaz G; Dubsky P; Exner R; Fansa H; Hager C; Reisenberger K; Singer CF; Reitsamer R; Reinisch M; Winkler J; Lam GT; Fehr MK; Naydina T; Kohlik M; Clerc K; Ostapenko V; Fitzal F; Nussbaumer R; Maggi N; Schulz A; Markellou P; Lelièvre L; Egle D; Heil J; Knauer M
Breast; 2021 Dec; 60():98-110. PubMed ID: 34555676
[TBL] [Abstract][Full Text] [Related]
15. Impact of sentinel lymph node biopsy by ultrasound-guided core needle biopsy for patients with suspicious node positive breast cancer.
Nakamura R; Yamamoto N; Miyaki T; Itami M; Shina N; Ohtsuka M
Breast Cancer; 2018 Jan; 25(1):86-93. PubMed ID: 28735457
[TBL] [Abstract][Full Text] [Related]
16. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
[TBL] [Abstract][Full Text] [Related]
17. Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy.
Balasubramanian R; Morgan C; Shaari E; Kovacs T; Pinder SE; Hamed H; Sever AR; Kothari A
Eur J Surg Oncol; 2020 Jun; 46(6):1028-1033. PubMed ID: 31879050
[TBL] [Abstract][Full Text] [Related]
18. Development of a predictive score of axillary lymph node dissection based on targeted axillary dissection in patients with breast cancer diagnosis, affected lymph nodes, and neoadjuvant treatment.
Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL
Surg Oncol; 2021 Sep; 38():101629. PubMed ID: 34171793
[TBL] [Abstract][Full Text] [Related]
19. Patterns in the Use of Axillary Operations for Patients with Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis.
Srour MK; Tseng J; Luu M; Alban RF; Giuliano AE; Chung A
Ann Surg Oncol; 2019 Oct; 26(10):3305-3311. PubMed ID: 31342364
[TBL] [Abstract][Full Text] [Related]
20. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer with axillary node metastasis: A survey of clinical practice.
Lee SB; Yu JH; Park H; Kim HJ; Park SH; Chae BJ; Youn HJ; Jung SY; Kim EK; Jung YS; Son BH
Asian J Surg; 2019 Jan; 42(1):314-319. PubMed ID: 30049563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]